Global RNA-Based Therapeutics and Vaccines Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • Category : Healthcare & Pharma
  • |
  • ID : 681598
  • |
  • Publishe Date : 12-Nov-18
  • |
  • No of Pages: 117
  • |
  • Publisher : Global Info Research

RNA-based biopharmaceuticals, which includes therapeutics and vaccines, is a relatively new class of treatment and prophylactic for a number of chronic and rare diseases, including cancer, diabetes, tuberculosis and certaincardiovascular conditions.

Scope of the Report:
This report studies the RNA-Based Therapeutics and Vaccines market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the RNA-Based Therapeutics and Vaccines market by product type and applications/end industries.
RNA-based biopharmaceuticals are a relatively new class of therapies that are demonstrating significant growth and potential for the treatment and prevention of chronic and rare diseases.
The global RNA-Based Therapeutics and Vaccines market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of RNA-Based Therapeutics and Vaccines.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers
Alnylam Pharmaceuticals
Arbutus Biopharma
Arrowhead Pharmaceuticals
BioNTech
CureVac
Dicerna Pharmaceuticals
Regulus Therapeutics
Marina Biotech
MiRagen Therapeutics
Moderna Therapeutics
Quark Pharmaceuticals
Roche
Sylentis

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
RNA-Based Therapeutics
RNA-Based Vaccines

Market Segment by Applications, can be divided into
Oncology
Immunology
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Genetic Diseases
Others

Table of Contents

1 RNA-Based Therapeutics and Vaccines Market Overview
1.1 Product Overview and Scope of RNA-Based Therapeutics and Vaccines
1.2 Classification of RNA-Based Therapeutics and Vaccines by Types
1.2.1 Global RNA-Based Therapeutics and Vaccines Revenue Comparison by Types (2017-2023)
1.2.2 Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Types in 2017
1.2.3 RNA-Based Therapeutics
1.2.4 RNA-Based Vaccines
1.3 Global RNA-Based Therapeutics and Vaccines Market by Application
1.3.1 Global RNA-Based Therapeutics and Vaccines Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Oncology
1.3.3 Immunology
1.3.4 Ophthalmology
1.3.5 Cardiovascular Diseases
1.3.6 Infectious Diseases
1.3.7 Genetic Diseases
1.3.8 Others
1.4 Global RNA-Based Therapeutics and Vaccines Market by Regions
1.4.1 Global RNA-Based Therapeutics and Vaccines Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) RNA-Based Therapeutics and Vaccines Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) RNA-Based Therapeutics and Vaccines Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) RNA-Based Therapeutics and Vaccines Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) RNA-Based Therapeutics and Vaccines Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) RNA-Based Therapeutics and Vaccines Status and Prospect (2013-2023)
1.5 Global Market Size of RNA-Based Therapeutics and Vaccines (2013-2023)
2 Manufacturers Profiles
2.1 Alnylam Pharmaceuticals
2.1.1 Business Overview
2.1.2 RNA-Based Therapeutics and Vaccines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.2 Arbutus Biopharma
2.2.1 Business Overview
2.2.2 RNA-Based Therapeutics and Vaccines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.3 Arrowhead Pharmaceuticals
2.3.1 Business Overview
2.3.2 RNA-Based Therapeutics and Vaccines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.4 BioNTech
2.4.1 Business Overview
2.4.2 RNA-Based Therapeutics and Vaccines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 BioNTech RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.5 CureVac
2.5.1 Business Overview
2.5.2 RNA-Based Therapeutics and Vaccines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 CureVac RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.6 Dicerna Pharmaceuticals
2.6.1 Business Overview
2.6.2 RNA-Based Therapeutics and Vaccines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.7 Regulus Therapeutics
2.7.1 Business Overview
2.7.2 RNA-Based Therapeutics and Vaccines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.8 Marina Biotech
2.8.1 Business Overview
2.8.2 RNA-Based Therapeutics and Vaccines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Marina Biotech RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.9 MiRagen Therapeutics
2.9.1 Business Overview
2.9.2 RNA-Based Therapeutics and Vaccines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.10 Moderna Therapeutics
2.10.1 Business Overview
2.10.2 RNA-Based Therapeutics and Vaccines Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.11 Quark Pharmaceuticals
2.11.1 Business Overview
2.11.2 RNA-Based Therapeutics and Vaccines Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.12 Roche
2.12.1 Business Overview
2.12.2 RNA-Based Therapeutics and Vaccines Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Roche RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.13 Sylentis
2.13.1 Business Overview
2.13.2 RNA-Based Therapeutics and Vaccines Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Sylentis RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
3 Global RNA-Based Therapeutics and Vaccines Market Competition, by Players
3.1 Global RNA-Based Therapeutics and Vaccines Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 RNA-Based Therapeutics and Vaccines Players Market Share
3.2.2 Top 10 RNA-Based Therapeutics and Vaccines Players Market Share
3.3 Market Competition Trend
4 Global RNA-Based Therapeutics and Vaccines Market Size by Regions
4.1 Global RNA-Based Therapeutics and Vaccines Revenue and Market Share by Regions
4.2 North America RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
4.3 Europe RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
4.5 South America RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
5 North America RNA-Based Therapeutics and Vaccines Revenue by Countries
5.1 North America RNA-Based Therapeutics and Vaccines Revenue by Countries (2013-2018)
5.2 USA RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
5.3 Canada RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
5.4 Mexico RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
6 Europe RNA-Based Therapeutics and Vaccines Revenue by Countries
6.1 Europe RNA-Based Therapeutics and Vaccines Revenue by Countries (2013-2018)
6.2 Germany RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
6.3 UK RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
6.4 France RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
6.5 Russia RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
6.6 Italy RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
7 Asia-Pacific RNA-Based Therapeutics and Vaccines Revenue by Countries
7.1 Asia-Pacific RNA-Based Therapeutics and Vaccines Revenue by Countries (2013-2018)
7.2 China RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
7.3 Japan RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
7.4 Korea RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
7.5 India RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
8 South America RNA-Based Therapeutics and Vaccines Revenue by Countries
8.1 South America RNA-Based Therapeutics and Vaccines Revenue by Countries (2013-2018)
8.2 Brazil RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
8.3 Argentina RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
8.4 Colombia RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue RNA-Based Therapeutics and Vaccines by Countries
9.1 Middle East and Africa RNA-Based Therapeutics and Vaccines Revenue by Countries (2013-2018)
9.2 Saudi Arabia RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
9.3 UAE RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
9.4 Egypt RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
9.5 Nigeria RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
9.6 South Africa RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
10 Global RNA-Based Therapeutics and Vaccines Market Segment by Type
10.1 Global RNA-Based Therapeutics and Vaccines Revenue and Market Share by Type (2013-2018)
10.2 Global RNA-Based Therapeutics and Vaccines Market Forecast by Type (2018-2023)
10.3 RNA-Based Therapeutics Revenue Growth Rate (2013-2023)
10.4 RNA-Based Vaccines Revenue Growth Rate (2013-2023)
11 Global RNA-Based Therapeutics and Vaccines Market Segment by Application
11.1 Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Application (2013-2018)
11.2 RNA-Based Therapeutics and Vaccines Market Forecast by Application (2018-2023)
11.3 Oncology Revenue Growth (2013-2018)
11.4 Immunology Revenue Growth (2013-2018)
11.5 Ophthalmology Revenue Growth (2013-2018)
11.6 Cardiovascular Diseases Revenue Growth (2013-2018)
11.7 Infectious Diseases Revenue Growth (2013-2018)
11.8 Genetic Diseases Revenue Growth (2013-2018)
11.9 Others Revenue Growth (2013-2018)
12 Global RNA-Based Therapeutics and Vaccines Market Size Forecast (2018-2023)
12.1 Global RNA-Based Therapeutics and Vaccines Market Size Forecast (2018-2023)
12.2 Global RNA-Based Therapeutics and Vaccines Market Forecast by Regions (2018-2023)
12.3 North America RNA-Based Therapeutics and Vaccines Revenue Market Forecast (2018-2023)
12.4 Europe RNA-Based Therapeutics and Vaccines Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific RNA-Based Therapeutics and Vaccines Revenue Market Forecast (2018-2023)
12.6 South America RNA-Based Therapeutics and Vaccines Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa RNA-Based Therapeutics and Vaccines Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure RNA-Based Therapeutics and Vaccines Picture
Table Product Specifications of RNA-Based Therapeutics and Vaccines
Table Global RNA-Based Therapeutics and Vaccines and Revenue (Million USD) Market Split by Product Type
Figure Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Types in 2017
Figure RNA-Based Therapeutics Picture
Figure RNA-Based Vaccines Picture
Table Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) by Application (2013-2023)
Figure RNA-Based Therapeutics and Vaccines Revenue Market Share by Applications in 2017
Figure Oncology Picture
Figure Immunology Picture
Figure Ophthalmology Picture
Figure Cardiovascular Diseases Picture
Figure Infectious Diseases Picture
Figure Genetic Diseases Picture
Figure Others Picture
Table Global Market RNA-Based Therapeutics and Vaccines Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate (2013-2023)
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Type and Applications
Table Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
Table Arbutus Biopharma Basic Information, Manufacturing Base and Competitors
Table Arbutus Biopharma RNA-Based Therapeutics and Vaccines Type and Applications
Table Arbutus Biopharma RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
Table Arrowhead Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Type and Applications
Table Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
Table BioNTech Basic Information, Manufacturing Base and Competitors
Table BioNTech RNA-Based Therapeutics and Vaccines Type and Applications
Table BioNTech RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
Table CureVac Basic Information, Manufacturing Base and Competitors
Table CureVac RNA-Based Therapeutics and Vaccines Type and Applications
Table CureVac RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
Table Dicerna Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Type and Applications
Table Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
Table Regulus Therapeutics Basic Information, Manufacturing Base and Competitors
Table Regulus Therapeutics RNA-Based Therapeutics and Vaccines Type and Applications
Table Regulus Therapeutics RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
Table Marina Biotech Basic Information, Manufacturing Base and Competitors
Table Marina Biotech RNA-Based Therapeutics and Vaccines Type and Applications
Table Marina Biotech RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
Table MiRagen Therapeutics Basic Information, Manufacturing Base and Competitors
Table MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Type and Applications
Table MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
Table Moderna Therapeutics Basic Information, Manufacturing Base and Competitors
Table Moderna Therapeutics RNA-Based Therapeutics and Vaccines Type and Applications
Table Moderna Therapeutics RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
Table Quark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Type and Applications
Table Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche RNA-Based Therapeutics and Vaccines Type and Applications
Table Roche RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
Table Sylentis Basic Information, Manufacturing Base and Competitors
Table Sylentis RNA-Based Therapeutics and Vaccines Type and Applications
Table Sylentis RNA-Based Therapeutics and Vaccines Revenue, Gross Margin and Market Share (2016-2017)
Table Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) by Players (2013-2018)
Table Global RNA-Based Therapeutics and Vaccines Revenue Share by Players (2013-2018)
Figure Global RNA-Based Therapeutics and Vaccines Revenue Share by Players in 2016
Figure Global RNA-Based Therapeutics and Vaccines Revenue Share by Players in 2017
Figure Global Top 5 Players RNA-Based Therapeutics and Vaccines Revenue Market Share in 2017
Figure Global Top 10 Players RNA-Based Therapeutics and Vaccines Revenue Market Share in 2017
Figure Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) by Regions (2013-2018)
Table Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Regions (2013-2018)
Figure Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Regions (2013-2018)
Figure Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Regions in 2017
Figure North America RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Figure Europe RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Figure South America RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Table North America RNA-Based Therapeutics and Vaccines Revenue by Countries (2013-2018)
Table North America RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries (2013-2018)
Figure North America RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries (2013-2018)
Figure North America RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries in 2017
Figure USA RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Figure Canada RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Figure Mexico RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Table Europe RNA-Based Therapeutics and Vaccines Revenue (Million USD) by Countries (2013-2018)
Figure Europe RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries (2013-2018)
Figure Europe RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries in 2017
Figure Germany RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Figure UK RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Figure France RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Figure Russia RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Figure Italy RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Table Asia-Pacific RNA-Based Therapeutics and Vaccines Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries in 2017
Figure China RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Figure Japan RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Figure Korea RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Figure India RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Figure Southeast Asia RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Table South America RNA-Based Therapeutics and Vaccines Revenue by Countries (2013-2018)
Table South America RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries (2013-2018)
Figure South America RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries (2013-2018)
Figure South America RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries in 2017
Figure Brazil RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Figure Argentina RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Figure Colombia RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Table Middle East and Africa RNA-Based Therapeutics and Vaccines Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa RNA-Based Therapeutics and Vaccines Revenue Market Share by Countries in 2017
Figure Saudi Arabia RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Figure UAE RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Figure Egypt RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Figure Nigeria RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Figure South Africa RNA-Based Therapeutics and Vaccines Revenue and Growth Rate (2013-2018)
Table Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) by Type (2013-2018)
Table Global RNA-Based Therapeutics and Vaccines Revenue Share by Type (2013-2018)
Figure Global RNA-Based Therapeutics and Vaccines Revenue Share by Type (2013-2018)
Figure Global RNA-Based Therapeutics and Vaccines Revenue Share by Type in 2017
Table Global RNA-Based Therapeutics and Vaccines Revenue Forecast by Type (2018-2023)
Figure Global RNA-Based Therapeutics and Vaccines Market Share Forecast by Type (2018-2023)
Figure Global RNA-Based Therapeutics Revenue Growth Rate (2013-2018)
Figure Global RNA-Based Vaccines Revenue Growth Rate (2013-2018)
Table Global RNA-Based Therapeutics and Vaccines Revenue by Application (2013-2018)
Table Global RNA-Based Therapeutics and Vaccines Revenue Share by Application (2013-2018)
Figure Global RNA-Based Therapeutics and Vaccines Revenue Share by Application (2013-2018)
Figure Global RNA-Based Therapeutics and Vaccines Revenue Share by Application in 2017
Table Global RNA-Based Therapeutics and Vaccines Revenue Forecast by Application (2018-2023)
Figure Global RNA-Based Therapeutics and Vaccines Market Share Forecast by Application (2018-2023)
Figure Global Oncology Revenue Growth Rate (2013-2018)
Figure Global Immunology Revenue Growth Rate (2013-2018)
Figure Global Ophthalmology Revenue Growth Rate (2013-2018)
Figure Global Cardiovascular Diseases Revenue Growth Rate (2013-2018)
Figure Global Infectious Diseases Revenue Growth Rate (2013-2018)
Figure Global Genetic Diseases Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global RNA-Based Therapeutics and Vaccines Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global RNA-Based Therapeutics and Vaccines Revenue Market Share Forecast by Regions (2018-2023)
Figure North America RNA-Based Therapeutics and Vaccines Revenue Market Forecast (2018-2023)
Figure Europe RNA-Based Therapeutics and Vaccines Revenue Market Forecast (2018-2023)
Figure Asia-Pacific RNA-Based Therapeutics and Vaccines Revenue Market Forecast (2018-2023)
Figure South America RNA-Based Therapeutics and Vaccines Revenue Market Forecast (2018-2023)
Figure Middle East and Africa RNA-Based Therapeutics and Vaccines Revenue Market Forecast (2018-2023)

Choose License Type